Similarly, serum level of FSIP1 in patients with PR-positive breast cancer was significantly higher than that in PR-negative cases (5, 357 ± 3, 066 pg/ml vs. 3, 392 ± 2, 638 pg/ml, p < 0.0001; Figure 2C). The gene discussed is FSIP1; the disease is breast carcinoma.